Terns Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 11.77

TERN Stock  USD 7.08  0.72  11.32%   
Terns Pharmaceuticals' future price is the expected price of Terns Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Terns Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Terns Pharmaceuticals Backtesting, Terns Pharmaceuticals Valuation, Terns Pharmaceuticals Correlation, Terns Pharmaceuticals Hype Analysis, Terns Pharmaceuticals Volatility, Terns Pharmaceuticals History as well as Terns Pharmaceuticals Performance.
To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.
  
Please specify Terns Pharmaceuticals' target price for which you would like Terns Pharmaceuticals odds to be computed.

Terns Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Terns Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Terns Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Terns Pharmaceuticals generated a negative expected return over the last 90 days
Terns Pharmaceuticals has high historical volatility and very poor performance
Terns Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (90.21 M) with profit before overhead, payroll, taxes, and interest of 1000 K.
Terns Pharmaceuticals currently holds about 139.81 M in cash with (67.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.51.
Terns Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Over 98.0% of the company shares are owned by institutional investors

Terns Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Terns Stock often depends not only on the future outlook of the current and potential Terns Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Terns Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding71.3 M
Cash And Short Term Investments263.4 M

Terns Pharmaceuticals Technical Analysis

Terns Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Terns Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Terns Pharmaceuticals. In general, you should focus on analyzing Terns Stock price patterns and their correlations with different microeconomic environments and drivers.

Terns Pharmaceuticals Predictive Forecast Models

Terns Pharmaceuticals' time-series forecasting models is one of many Terns Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Terns Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Terns Pharmaceuticals

Checking the ongoing alerts about Terns Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Terns Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Terns Pharmaceuticals generated a negative expected return over the last 90 days
Terns Pharmaceuticals has high historical volatility and very poor performance
Terns Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (90.21 M) with profit before overhead, payroll, taxes, and interest of 1000 K.
Terns Pharmaceuticals currently holds about 139.81 M in cash with (67.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.51.
Terns Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Over 98.0% of the company shares are owned by institutional investors
When determining whether Terns Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Terns Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Terns Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Terns Pharmaceuticals Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.